Memorial Sloan Kettering Cancer Commack (Limited Protocol Activities)
Memorial Sloan Kettering Cancer Commack (Limited Protocol Activities)
Commack, New York, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 2 | 2026-05-11 | NCT04262154 | |
| Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma | Advanced Sarcoma | Active, not recruiting | Phase 2 | 2026-04-21 | NCT04784247 |